Resources & Articles

Check out this transcript of PicnicHealth’s Chief Scientific Advisor, Dr. Nancy Dreyer, talking with AJMC about how the direct-to-patient approach is superior to traditional observational research methods. She focuses on the collection of better real-world data and how patients can benefit.

Read about how AI is empowering real-world evidence generation in observational research as well as the limitations of using AI within this setting.

Q&A with PicnicHealth Chief Commercial Officer, Rachael Thomas Higgins

In this article with PharmaPhorum, our Chief Scientific Advisor, Dr. Nancy Dreyer, provides actionable guidelines on how to integrate direct-to-patient approaches at every stage of your study. See why she believes patient-centric observational research is better fit to answer complex research questions.

In honor of Rare Disease Day, we dived into an insightful Q&A session with PicnicHealth's Chief Medical Officer, Daniel R. Drozd, an MD at the forefront of pioneering healthcare research.

We are excited to announce the launch of PicnicStudies! With this new solution, run faster and more efficient observational studies from end-to-end.

Join us for a cutting-edge webinar on the intersection of decentralized research and real-world data. Learn from industry experts about the evolving drug development landscape.

In this engaging webinar, Clara, Heather, and Dan lead a discussion on the exciting ways stakeholders are optimizing registries to enhance research insights. The session explores the concept of the "Reimagined Registry" and delves into the characteristics of traditional registries. Patient registries are introduced as organized systems utilizing observational study methods to collect standardized patient information. These registries play a pivotal role in providing valuable real-world data for diverse research needs and inquiries. Join us in uncovering the potential of reimagined registries for research excellence.

Get to know Sara Snell Taylor, Senior Epidemiologist at PicnicHealth and discover how she leverages real-world data to improve patient outcomes

Roche has selected PicnicHealth as its partner to study Alzhemier’s disease (AD) in real world patients through their latest project, EMPOWER AD. The partnership leverages PicnicHealth’s end-to-end patient-centric approach to building registries from recruitment, to medical records retrieval, and machine learning (ML)-driven, human-curated data abstraction.

Welcome to PicnicHealth’s Team Spotlight series, where we introduce you to the talented people that are working behind the scenes at PicnicHealth. Today you’ll get to know Justin Maslin, the Engineering Manager for the Care Experience team at PicnicHealth

In the era of telehealth and increased inclusivity, the FDA's recommendations pave the way for more patient-centric trials held at non-traditional locations. This game-changing guidance provides invaluable insights into DCT design, remote trial visits, electronic informed consent, safety monitoring, and leveraging digital health technologies.

The global health economics and outcomes research (HEOR) market continues to grow year over year and is estimated to reach 2.46 billion by 2026. Read on for a breakdown of the top 5 trends driving this exciting industry growth.

Whether or not you had the opportunity to attend the three action-packed days of ISPOR this year, we’ve got you covered with a summary of 4 major themes that emerged.

With increasing applications of real-world data (RWD) upstream in the drug development lifecycle, it’s critical to recognize that there is no one-size-fits-all approach. So how can one incorporate different types of data from patients into clinical trials? Through conversation with a panel of experts from the biopharma industry and health technology companies, we will discuss scenarios when patient-mediated, tokenized and/or site-based approaches are warranted. Gaelan Ritter, Sneha Kishnani, and Andrew Larsen share their unique perspectives on the importance of a tailored yet flexible strategy and the potential value this can unlock for researchers and patients alike.Watch the recorded webinar or read the transcript below to explore design considerations for incorporating different types of real-world data into clinical trials.

This year, the FDA shed light on important, cross-cutting considerations for patient-level, real-world data to serve as an external control arm. Our new blog post highlights what you need to know - and the data you need to have - to conduct an externally controlled trial.

The studies presented at the HTRS Scientific Symposium showcase some of the many ways PicnicHealth is partnering with leading researchers to deliver robust real-world evidence and improving patient care across different therapeutic areas, including rare diseases, hematology, immunology, neurology, and oncology

PicnicHealth | Does a recent FDA approval signal changes for the wider industry when it comes to RWE?FDA approvals supported by Real-World Evidence (RWE) are rising. Life science companies would be remiss not to consider including evidence on the natural history of disease, unmet medical need, and/or patient-reported outcomes in their regulatory strategies. PicnicHealth has extensive experience helping life science companies execute strategies to leverage Real-World Data (RWD) and incorporate RWE into their research and business planning. Uncovering experiences and outcomes from real patients is at the heart of it all. Contact us to discuss how we can partner on confirmatory evidence studies to strengthen your regulatory submission.

This webinar explores relevant examples of how Data Science and Digital Health are accelerating pharmaceutical innovation and driving impact for patients. Bringing together global experts with diverse perspectives spanning regulatory, R&D and health tech, this conversation highlights innovative, RWD-driven approaches to drug development and regulatory decision-making. Najat, Noga, Jesper, and Evelyn discuss the need for different types of data to construct a complete clinical picture – and how a data-driven approach can drive impact across both research and clinical practice.

We sat down with Evelyn Pyper, Senior Evidence Strategy Manager at PicnicHealth, to talk about successes, limitations, and areas for growth within the wearables industry.

PicnicHealth is launching a four-part webinar series that aims to reframe the “ROI” for RWE generation and tackle the question: beyond the return on investment for RWE, what is the risk of inaction?

2022 was the biggest and most exciting year yet for PicnicHealth - not only for our team, but for our Change Champions, PicnicHealth users, and research partners. We want to thank everyone for being a part of this incredible community and making this past year possible. Before we jump into 2023, join us as we look back at our favorite moments of last year. We raised $60 million in Series C funding! PicnicHealth is ecstatic to have raised a $60m Series C to help build deep, complete, and clinically-rich real-world datasets in several new diseases. The team spent the year growing our research program portfolio, connecting with new patient populations to initiate new studies; introducing new capabilities to our patient app to make it easier for patients to tell us more about their experiences by completing surveys, diaries, and more; and building new data features to help researchers gain new insights faster.

Mental health can mean a lot of different things to different people with seemingly vague definitions. MentalHealth.gov takes broad strokes to include emotional, psychological, and social well-being at the interface of how a person thinks, acts, and feels. Indicators that something is out of balance can present with a number of uncomfortable behaviors including having low or no energy, having unexplained aches or pains, or experiencing severe mood swings. It would be difficult to look through the entire list of possible symptoms and not relate at some level at some point in time, suggesting that mental wellness is just one fabric to the many layers that influence how we function on any given day. Unresolved or persistent mental health issues can lead to a diagnosis of mental illness, but it feels more fluid than other conditions or diseases that use more measurable diagnostic criteria such as abnormal lab values or imaging modalities to diagnose.

PicnicHealth’s research partners Roche-Genentech and other key opinion leaders in the hemophilia space presented data from PicnicHealth’s Hemophilia Cohort in an oral podium presentation and poster session at ASH 2022.

Patient-centric real-world data and evidence are especially conducive to accelerating research of neurodegenerative diseases.